Apanemia Health Centre

Archive for July, 2008

Acquired agranulocytosis is a circumstance that results from bankruptcy of a person’s ivory marrow to develop an adequate amount of light-colored blood cells, or increased devastation of the light-colored blood cells. It is is characterized by a serious decrease in the amount of light-colored blood cells (granulocytes) in the circulating blood.

The figure granulocyte refers to grain-like bodies within the cubicle. Granulocytes include basophils, eosinophils, and neutrophils. The symptoms of this disorder go about as the outcome of intervention in the output of granulocytes in the ivory marrow. People with acquired agranulocytosis are vulnerable to a kind of bacterial infections, normally caused by otherwise harmless bacterium establish in the system. Not infrequently, traumatic ulcers too produce in mucous membranes that line the lip and the gastrointestinal tract.

People with acquired agranulocytosis are vulnerable to a kind of bacterial infections, normally caused by otherwise harmless bacterium establish in the system. Not infrequently, traumatic ulcers too produce in mucous membranes that line the lip and the gastrointestinal parcel. Causes can include drugs, chemicals, infective agents, ionizing radioactivity, exempt mechanisms, and heritable hereditary aberrations. Although “agranulocytosis” literally means no granulocytes, there may, in fact, be some granulocytes but overly few of them, i. e. granulocytopenia. Agranulocytosis can be hereditary and inherited or it can be acquired as, for instance, a facet of leukemia. Acquired agranulocytosis occurs somewhat more often in women than in men, perhaps because of their increased pace of medicine utilization. Whether this high frequency is related to the increased incidence of autoimmune disease in women is unidentified.

In patients who have no symptoms of transmission, administration consists of good moniting with sequential blood counts, withdrawal of the offending broker (e. g. medicine) and general advice on the meaning of fever. Infection in patients with reduced light-colored blood cubicle counts is normally treated desperately, and normally includes a broad-spectrum penicillin or cephalosporin or meropenem in combination with gentamycin or amikacin. Transfusion of light-colored blood cells to supplant shortfall may be of welfare in sure folk.

Depending on the reason, some folk may gain from treatments with granulocyte colony-stimulating element or granulocyte-macrophage colony-stimulating element. Aplastic anemia can be effectively treated by stem-cell transplant or immunosuppressive therapy. Transplantation is therapeutic but is better used for younger patients who have histocompatible sibling donors. Antithymocyte globulin and cyclosporine reestablish hematopoiesis in roughly two thirds of patients.

Acute myeloid leukemia (AML), is a cancer of the myeloid line of white blood cells. It is transparent by the rapid proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells. Acute myelocytic leukemia, also known as acute myelogenous leukemia, may lead to overgrowth of the gums and blurred vision. Acute leukemia is believed to begin in a single somatic hematopoietic progenitor that transforms to a cell incapable of normal differentiation. Many of these cells no longer possess the normal property of apoptosis, or programmed cell death. Leukemogenesis is frequently associated with chromosomal abnormalities and gene translocations. Many translocations are characteristic of a particular subtype of acute leukemia and often convey additional prognostic information to the clinician.

Tobacco smoking appears to increase the incidence of this form of leukemia. The signs and symptoms of acute myelocytic leukemia result from the fact that, as the leukemic clone of cells grows, it tends to displace or interfere with the development of normal blood cells in the bone marrow. This leads to neutropenia, anemia, and thrombocytopenia. Acute myeloid leukemia is the most common acute leukemia affecting adults, and its incidence increases with age. Although several risk factors for acute myelocytic leukemia have been identified, the specific cause of AML remains unclear. As an acute leukemia, AML progresses rapidly and is typically fatal within weeks or months if left untreated. Exposure to certain chemicals can also cause leukemia. Workers exposed to benzene over long periods have an increased risk of developing acute myelocytic leukemia.

Tests such as chest X rays and examination of the spinal fluid for leukemic cells can help doctors determine how far the disease has spread. The identification of acute myelocytic leukemia is also similar to that of acute lymphocytic leukemia. The symptoms of AML are caused by replacement of normal bone marrow with leukemic cells, resulting in a drop in red blood cells, platelets, and normal white blood cells. These symptoms include fatigue, shortness of breath, easy bruising and bleeding, and increased risk of infection. In rare cases, a mediastinal mass may cause symptoms of respiratory insufficiency or superior vena cava syndrome. A bone marrow biopsy is almost always performed to confirm the diagnosis and to distinguish AML from other types of leukemia.

Acute myeloid leukemia is a potentially improvable disease, but only a minority of patients are cured with current therapy. AML is treated initially with chemotherapy aimed at inducing a remission; some patients may go on to receive a hematopoietic stem cell transplant. Once acute myelocytic leukemia is in remission, the person usually receives a few courses of additional chemotherapy a few weeks or months after the initial treatment to help ensure that as many leukemia cells as possible are destroyed. People who have not responded to treatment and younger people who are in remission but who are likely to have a high rate of relapse may be given high-dose chemotherapy with stem cell transplantation. A new drug, gemtuzumab ozogamicin, which combines an antibody with a chemotherapy drug as an attempt to specifically “target” the leukemia cells, is effective in some people after relapse has occurred. The long-term benefits of the drug have not been determined.

Acute promyelocytic leukemia, a malignancy of the ivory marrow in which there is an inadequacy of old blood cells in the myeloid cable of cells and a surplus of immature cells called promyelocytes. Acute promyelocytic leukemia is a subtype of intense myelogenous leukemia, a cancer of the blood and ivory marrow. The signs and symptoms particular to APL outcome from a shortfall of natural blood cells payable to crowding out of natural blood cell-producing ivory marrow by the leukemia cells. In Acute promyelocytic leukemia, there is an irregular accretion of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acidic receptor alpha gene and is unusual from new forms of AML in its responsiveness to all trans retinoic acidic therapy.

Acute promyelocytic leukemia is normally associated with a shortfall of natural light-colored blood cells (a circumstance called leukopenia) and, in specific, overly few old granulocytes. This results in a high danger of infections. The peak incidence of APL is in inexperienced adults. APL is considered a character of AML and is classified as the M3 variation of AML in the internationally accepted french american british classification. Signs and symptoms of intense promyelocytic leukemia are related to new forms of intense promyelocytic leukemia. Symptoms include weight departure or departure of appetite, shortness of breather with exertion, fever, tiredness, anemia, simple bruising or bleeding, petechiae, ivory pain and multilateral pain and relentless or regular infections.

Acute promyelocytic leukemia can be distinguished from new types of AML based on morphologic testing of an ivory marrow biopsy or aspirate. Definitive diagnosis requires examination for the RARá fusion gene. The handling of APL differs from that for all new forms of AML. Most intense promyelocytic leukemia patients are now treated with all-trans retinoic acid. All-trans retinoic acid (ATRA) is a kind of differentiation therapy. It can cause a comprehensive absolution in most patients with APL by causing the APL-blasts to grow. ATRA is typically combined with anthracycline based chemotherapy resulting in a clinical absolution in roughly 90% of patients. ATRA therapy is associated with the unusual position consequence of retinoic acidic syndrome. This is associated with the growth of dyspnea, fever, weight increase, incidental edema and is treated with dexamethasone.

The prospect for acute promyelocytic leukemia depends on a number of factors including the white blood cell count at the time of diagnosis, etc. Treatment options for patients with relapsed disease include arsenic trioxide and allogeneic stem cell transplant. Bone marrow transplantation may be successful in achieving a cure, but it is an option for only a fraction of the younger relapsed patients. Stem cell transplant is a method of giving chemotherapy and replacing blood-forming cells that are abnormal or destroyed by the cancer treatment. Stem cells are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. Arsenic trioxide is the standard of care for APL patients whose disease returns after or does not respond to initial treatment.

HIV Drugs And Side Effects Resistance to some antiretroviral drugs can limit which treatment options are available to you in the future. If HIV is resistant to one drug, it will sometimes be resistant to similar drugs in the same group. This is called cross-resistance and it means that some anti-HIV drugs will not work even though you have not used them before. Most of the anti-HIV drugs have known side effects, but this does not mean that everyone who takes them will experience side effects. The most common side effects are nausea and feeling tired.

The goal of anti-HIV treatment is to reduce the amount of HIV in the body. The treatment should stop you from becoming ill for many years. Sometimes the antiretroviral therapy works without any major problems or setbacks, but sometimes there can be difficulties. The majority of studies done have shown that Side Effects of HIV drugs during Pregnancy does not increase the risk of birth defects. However, there are certain HIV drugs like Sustiva, and certain combinations of drugs like d4T and ddI, that should not be used by pregnant women because of potential problems for the mother or the baby. Lactic Acidosis is a buildup of lactic acid in the blood. It is a rare but serious complication of the NRTI (nucleoside reverse transcriptase inhibitor) class of HIV drugs, such as d4T and ddI.

Women (especially pregnant women), overweight people, and those with a long history of NRTI use are more likely to develop lactic acidosis. Some HIV symptoms include fatigue, nausea, vomiting, stomach pain, shortness of breath, and weakness in the arms and legs. If you notice any of these symptoms, call your doctor right away. Some drugs that are fine for non-pregnant women should be avoided during pregnancy.

These include cholesterol-lowering agents and PCP (pneumonia) medications. There are also drugs that are used after a woman delivers her baby to help stop the bleeding that can cause problems for women on HIV medicines. Speak to your doctor about all of your prescriptions to be sure there are no specific warnings for pregnant women or women taking HIV drugs.

HIV drugs have helped many people live longer, healthier lives. To get the most out of the drugs, it is important to take them correctly and be aware of potential side effects. If you have difficulty with a drug, don’t just stop taking it. Speak to your doctor. There is usually something that can be done about it, such as changing to another drug, altering the dose of that drug, or treating the side effect separately. While all the HIV drugs can cause side effects, not everyone will experience the same effect to the same extent. Speak to your doctor before starting any new treatment to find out what kind of side effects are possible.

It will help if you know what to expect and how to handle any problems that arise. Some important points: Side effects are most common in the first four to six weeks after starting a new medication After your body gets used to a new drug, the side effects usually lessen or go away Have doctor-recommended treatments for common side effects like diarrhea and nausea on hand Let your doctor know if you are experiencing side effects, especially if you are taking a drug that may cause a particularly serious problem Some HIV drugs may cause Menstrual Irregularities One small study suggested that women using Norvir (ritonavir) could be at greater risk for anemia due to excessive menstrual bleeding.

If you’re taking HIV therapy, watch out for any changes in your bleeding, and be sure to tell your doctor if you have heavier, prolonged, or more frequent periods. Being HIV+ and a woman puts you at higher risk for Bone Problems such as osteoporosis and osteopenia. These diseases cause weaker bones that can break more easily. So you should follow these instructions, Have your bone density checked with a DEXA scan 1 Get enough VitaminD and calcium. 2 Exercise 3 Stop smoking 4 Reduce your intake of caffeine and alcohol

Hemorrhoids are a medical condition caused by swelling of the blood vessels in the lower rectum and around the anus. Often very painful hemorrhoids can also bleed a small amount or enough to cause anemia. When hemorriods are severe enough to cause symptoms an examination by a medical professional should be preformed to emliminate the possibility of other problems such as colorectal cancers. Following an examination the patient will be able to get rid of bleeding hemorrhoids in one of many ways.

Medical therapy for bleeding hemorrhoids is aimed at both reducing the cause, often constipation and straining to pass hard stools, and heal the bleeding tissue by reducing the swelling and decreasing the inflammation. Constipation can be eliminated by dietary changings including more fiber and more water that result in softer stools. The chemical witch hazel will reduce the swelling of the blood vessels and hydrocortisone cream will reduce the inflammation. In combination these to therapies will get rid of the bleeding hemorrhoids in the majority of cases.

Slightly more invasive therapies are aimed at collapsing the blood vessels to stop the bleeding and relieve the irritation. This can be accomplished by “banding” or placing a rubber band like loop around the hemorrhoid to cut off the blood flow. Sclerotherapy is also used to inject and collapse the blood vessel(s) which stops the bleeding. Once the blood vessels are collapsed the irritated tissue heals with local care.

Surgical therapy is aimed at removing the blood vessels or at times even the tissue that contains the blood vessels in which the hemorrhoids have formed. After the hemorrhoidal tissue is remove a period of healing must occur. There is also a risk of recurrence especially if the intial cause is not treated. What ever treatment is utilized to get rid of the bleeding hemorrhoids care is important in preventing a reoccurance.